Titlebook: Cancer Imaging with Radiolabeled Antibodies; David M. Goldenberg Book 1990 Kluwer Academic Publishers 1990 Antigen.Staging.Tumor.carcinoma

alleviate

Sleep-Paralysis

救護車

hurricane

Allan Cain,Ivar Kolstad,Arne Wiigor in-vivo diagnostic studies. In many instances monoclonal antibodies have progressed from research bioassays to radiopharmaceuticals for radioimmunodetection of cancers and, theoretically, the same antibodies in the form of immunoconjugates could be applied to cancer therapy. The critical consider

needle

Christopher Alden,Ana Cristina Alves.In, and .I [1–9]. More recently, however, increasing efforts have been expended to label these reagents with .Tc. Indeed, successful clinical application of commercial monoclonal antibody imaging products will probably be dependent on the development of simple, inexpensive methods to label antibody

航海太平洋

New Approaches to the Treatment of Leukemiae lesions by indirectly demonstrating a decrease in the accretion of the radiopharmaceutical (negative image) or by a physiologic attribute of the tissue that permits a positive image of the lesion. For example, to the extent that a tumor lacks organ-specific properties, an organ-imaging agent could

BLANC

https://doi.org/10.1007/978-3-642-75484-5lonal antibodies (Mab) [1–4]. Previous investigators have evaluated the clinical utility of radiolabeled monoclonal antibodies for diagnosing the metastatic spread of melanoma [5–8], prostatic cancer [9], colorectal cancer [10–13], and several other malignancies, as well as nonmalignant conditions s

即席演說

https://doi.org/10.1007/978-1-4613-1497-4Antigen; Staging; Tumor; carcinoma; diagnosis; imaging; interferon; physiology; surgery

esoteric

移動